ZYPADHERA 210 mg, 300 mg, and 405 mg, powder and solvent for prolonged release suspension for injection *

• Company:

  Eli Lilly and Company (Ireland) Limited

• Status:

  No Recent Update

• Legal Category:

  Product subject to medical prescription which may not be renewed (A)

• Active Ingredient(s):

  Olanzapine pamoate monohydrate

  *Additional information is available within the SPC or upon request to the company